ID
16026
Beskrivning
Documentation part: Medical conditions & Lab A Randomised, Observer-blind, Multicentre, Non-inferiority, Comparative, Phase III Study of the Safety and Efficacy of Topical 1% SB-275833 Ointment, Applied Twice Daily for 5 Days, versus Topical 2% Sodium Fusidate Ointment Applied Three Times Daily for 7 Days in the Treatment of Adult and Paediatric Subjects with Impetigo. ClinicalTrials.gov Identifier: NCT00133874 Other Study ID Numbers: TOC100224 Responsible Party: GlaxoSmithKline
Nyckelord
Versioner (1)
- 2016-06-26 2016-06-26 -
Uppladdad den
26 juni 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Medical conditions & Lab Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874
Medical conditions & Lab Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874
Beskrivning
Electronically transferred Lab Data
Beskrivning
Date sample taken
Datatyp
date
Måttenheter
- DDMONYYYY
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0200345
Beskrivning
Not done
Datatyp
boolean
Alias
- UMLS CUI [1]
- C1272696
Beskrivning
Haem Lab type code
Datatyp
text
Alias
- UMLS CUI [1,1]
- C0018941
- UMLS CUI [1,2]
- C0805701
Beskrivning
Chem Lab type code
Datatyp
text
Alias
- UMLS CUI [1,1]
- C0005774
- UMLS CUI [1,2]
- C0805701
Beskrivning
Urin Lab type code
Datatyp
text
Alias
- UMLS CUI [1,1]
- C0042014
- UMLS CUI [1,2]
- C0805701
Similar models
Medical conditions & Lab Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874
C0022658 (UMLS CUI [2])
C0851341 (UMLS CUI [2])
C0200345 (UMLS CUI [1,2])
C0805701 (UMLS CUI [1,2])
C0805701 (UMLS CUI [1,2])
C0805701 (UMLS CUI [1,2])
Inga kommentarer